Clin2
NCT07176143Worth exploringNot yet recruiting

Stem cell treatment for severe uterine scarring and infertility

Intrauterine Adhesions

Part of Women’s health & pregnancy clinical trials.

This trial tests whether infusing special stem cells (from donated bone marrow) into the uterine artery can help thicken the womb lining in women with severe uterine scarring (adhesions) and a history of failed embryo transfers due to thin lining. The goal is to make it possible to successfully implant a frozen embryo and achieve pregnancy.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
60 people
Ages
20 years to 38 years
Study type
Interventional

Who can take part

  • Are between 20 and 38 years old.
  • Have a body mass index (BMI) between 18 and 27.
  • Have regular periods (every 27–35 days) for at least the last 6 months.
  • Have at least two good-quality frozen embryos stored (day 5 or day 6).
  • Have been diagnosed with severe intrauterine adhesions (scar tissue in the womb) and treated with surgery to remove them.
  • Have had a frozen embryo transfer canceled because the womb lining was too thin (less than 6 mm).

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06896747Recruiting· Phase 1/Phase 2
Stem cell therapy for thin uterine lining

This trial tests a new treatment using stem cell particles (exosomes) to help rebuild the lining of the womb in women whose lining is too thin after surgery for scar tissue. It may improve chances of success with IVF.

Xi'an, Shaanxi
NCT07536971Not yet recruiting
Treatment for uterine scar tissue to help with pregnancy

This study tests whether infusing a special blood product into the uterus can help heal scar tissue and improve the chances of becoming pregnant. It is for women with moderate to severe uterine adhesions who plan to have surgery to remove the scar tissue.

Beijing
NCT07611474Recruiting
Testing a treatment to prevent uterine scar tissue after surgery

This trial tests a new product designed to prevent scar tissue (adhesions) from forming inside the uterus after surgery. If you have uterine scar tissue causing fertility problems or irregular periods, this study may help determine if the treatment is safe and effective.

Changsha, Hunan
NCT07230600Recruiting· Phase 1
Stem cell therapy for thin uterine lining or scarring

This trial tests a new treatment for people with a thin uterine lining or uterine scarring that hasn't responded to other stem cell therapy. It might help improve the lining so pregnancy is possible.

Nanjing, Jiangsu
NCT05343572Recruiting· Early Phase 1
Stem cell treatment to improve abnormal uterine lining

This early-phase study tests whether mobilized stem cells from bone marrow can help women with certain abnormal uterine lining problems become healthier and possibly improve fertility. It’s aimed at people who are not pregnant and meet specific diagnoses and test results.

Orange, Connecticut
NCT07101484Enrolling by invitation
Study of a new liquid dressing for moderate-severe uterine scarring

This trial tests a new liquid dressing made from human cells to see if it is safe and helps heal moderate to severe uterine scarring (intrauterine adhesions) in women who want to have children. Participants will receive the dressing during a hysteroscopic procedure.

Nanjing, Jiangsu

Hear when a new Intrauterine Adhesions trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.